Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

Wang Li, Heyong Wang, Yan Yang, Tian Zhao, Zhixiong Zhang, Ye Tian, Zhaomie Shi, Xiaojun Peng, Fei Li, Yonghong Feng, Lei Zhang, Gening Jiang, Fan Zhang

Research output: Contribution to journalArticle

Abstract

Non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations treated with gefitinib, a tyrosine kinase inhibitor, will develop drug resistance. Ubiquitylation is one of major posttranslational modifications of proteins affecting the stability or function of proteins. However, the role of protein ubiquitylation in gefitinib resistance is poorly understood. To systematically identify the global change in protein expression and ubiquitylation during gefitinib resistance, a quantitative global proteome and ubiquitylome study in a pair of gefitinib-resistant and sensitive NSCLC cells is carried out. Altogether, changes in expression of 3773 proteins are quantified, and changes in ubiquitylation of 2893 lysine sites in 1415 proteins are measured in both cells. Interestingly, lysosomal and endocytic pathways, which are involved in autophagy regulation, are enriched with upregulated proteins or ubiquitylated proteins in gefitinib-resistant cells. In addition, HMGA2 overexpression or ALOX5 knockdown suppresses gefitinib resistance in NSCLC cells by inhibiting autophagy. Overall, these results reveal the previously unknown global ubiquitylome and proteomic features associated with gefitinib resistance, uncover the opposing roles of HMGA2 or ALOX5 in regulating gefitinib resistance and autophagy, and will help to identify new therapeutic targets in overcoming gefitinib resistance.

Original languageEnglish (US)
Article number1700388
JournalProteomics
Volume18
Issue number15
DOIs
StatePublished - Aug 1 2018

Fingerprint

Proteome
Non-Small Cell Lung Carcinoma
Cells
Ubiquitination
Autophagy
Proteins
gefitinib
Protein Stability
Post Translational Protein Processing
Drug Resistance
Proteomics
Protein-Tyrosine Kinases
Lysine
Mutation
Pharmaceutical Preparations

Keywords

  • gefitinib resistance
  • non-small cell lung cancer
  • proteome
  • ubiquitylome

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. / Li, Wang; Wang, Heyong; Yang, Yan; Zhao, Tian; Zhang, Zhixiong; Tian, Ye; Shi, Zhaomie; Peng, Xiaojun; Li, Fei; Feng, Yonghong; Zhang, Lei; Jiang, Gening; Zhang, Fan.

In: Proteomics, Vol. 18, No. 15, 1700388, 01.08.2018.

Research output: Contribution to journalArticle

Li, W, Wang, H, Yang, Y, Zhao, T, Zhang, Z, Tian, Y, Shi, Z, Peng, X, Li, F, Feng, Y, Zhang, L, Jiang, G & Zhang, F 2018, 'Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells', Proteomics, vol. 18, no. 15, 1700388. https://doi.org/10.1002/pmic.201700388
Li, Wang ; Wang, Heyong ; Yang, Yan ; Zhao, Tian ; Zhang, Zhixiong ; Tian, Ye ; Shi, Zhaomie ; Peng, Xiaojun ; Li, Fei ; Feng, Yonghong ; Zhang, Lei ; Jiang, Gening ; Zhang, Fan. / Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. In: Proteomics. 2018 ; Vol. 18, No. 15.
@article{1e5eb6009f88412d9df2adc12ca07418,
title = "Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells",
abstract = "Non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations treated with gefitinib, a tyrosine kinase inhibitor, will develop drug resistance. Ubiquitylation is one of major posttranslational modifications of proteins affecting the stability or function of proteins. However, the role of protein ubiquitylation in gefitinib resistance is poorly understood. To systematically identify the global change in protein expression and ubiquitylation during gefitinib resistance, a quantitative global proteome and ubiquitylome study in a pair of gefitinib-resistant and sensitive NSCLC cells is carried out. Altogether, changes in expression of 3773 proteins are quantified, and changes in ubiquitylation of 2893 lysine sites in 1415 proteins are measured in both cells. Interestingly, lysosomal and endocytic pathways, which are involved in autophagy regulation, are enriched with upregulated proteins or ubiquitylated proteins in gefitinib-resistant cells. In addition, HMGA2 overexpression or ALOX5 knockdown suppresses gefitinib resistance in NSCLC cells by inhibiting autophagy. Overall, these results reveal the previously unknown global ubiquitylome and proteomic features associated with gefitinib resistance, uncover the opposing roles of HMGA2 or ALOX5 in regulating gefitinib resistance and autophagy, and will help to identify new therapeutic targets in overcoming gefitinib resistance.",
keywords = "gefitinib resistance, non-small cell lung cancer, proteome, ubiquitylome",
author = "Wang Li and Heyong Wang and Yan Yang and Tian Zhao and Zhixiong Zhang and Ye Tian and Zhaomie Shi and Xiaojun Peng and Fei Li and Yonghong Feng and Lei Zhang and Gening Jiang and Fan Zhang",
year = "2018",
month = "8",
day = "1",
doi = "10.1002/pmic.201700388",
language = "English (US)",
volume = "18",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "15",

}

TY - JOUR

T1 - Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

AU - Li, Wang

AU - Wang, Heyong

AU - Yang, Yan

AU - Zhao, Tian

AU - Zhang, Zhixiong

AU - Tian, Ye

AU - Shi, Zhaomie

AU - Peng, Xiaojun

AU - Li, Fei

AU - Feng, Yonghong

AU - Zhang, Lei

AU - Jiang, Gening

AU - Zhang, Fan

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations treated with gefitinib, a tyrosine kinase inhibitor, will develop drug resistance. Ubiquitylation is one of major posttranslational modifications of proteins affecting the stability or function of proteins. However, the role of protein ubiquitylation in gefitinib resistance is poorly understood. To systematically identify the global change in protein expression and ubiquitylation during gefitinib resistance, a quantitative global proteome and ubiquitylome study in a pair of gefitinib-resistant and sensitive NSCLC cells is carried out. Altogether, changes in expression of 3773 proteins are quantified, and changes in ubiquitylation of 2893 lysine sites in 1415 proteins are measured in both cells. Interestingly, lysosomal and endocytic pathways, which are involved in autophagy regulation, are enriched with upregulated proteins or ubiquitylated proteins in gefitinib-resistant cells. In addition, HMGA2 overexpression or ALOX5 knockdown suppresses gefitinib resistance in NSCLC cells by inhibiting autophagy. Overall, these results reveal the previously unknown global ubiquitylome and proteomic features associated with gefitinib resistance, uncover the opposing roles of HMGA2 or ALOX5 in regulating gefitinib resistance and autophagy, and will help to identify new therapeutic targets in overcoming gefitinib resistance.

AB - Non-small cell lung cancer (NSCLC) patients carrying EGFR activating mutations treated with gefitinib, a tyrosine kinase inhibitor, will develop drug resistance. Ubiquitylation is one of major posttranslational modifications of proteins affecting the stability or function of proteins. However, the role of protein ubiquitylation in gefitinib resistance is poorly understood. To systematically identify the global change in protein expression and ubiquitylation during gefitinib resistance, a quantitative global proteome and ubiquitylome study in a pair of gefitinib-resistant and sensitive NSCLC cells is carried out. Altogether, changes in expression of 3773 proteins are quantified, and changes in ubiquitylation of 2893 lysine sites in 1415 proteins are measured in both cells. Interestingly, lysosomal and endocytic pathways, which are involved in autophagy regulation, are enriched with upregulated proteins or ubiquitylated proteins in gefitinib-resistant cells. In addition, HMGA2 overexpression or ALOX5 knockdown suppresses gefitinib resistance in NSCLC cells by inhibiting autophagy. Overall, these results reveal the previously unknown global ubiquitylome and proteomic features associated with gefitinib resistance, uncover the opposing roles of HMGA2 or ALOX5 in regulating gefitinib resistance and autophagy, and will help to identify new therapeutic targets in overcoming gefitinib resistance.

KW - gefitinib resistance

KW - non-small cell lung cancer

KW - proteome

KW - ubiquitylome

UR - http://www.scopus.com/inward/record.url?scp=85050890944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050890944&partnerID=8YFLogxK

U2 - 10.1002/pmic.201700388

DO - 10.1002/pmic.201700388

M3 - Article

VL - 18

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 15

M1 - 1700388

ER -